Please use this identifier to cite or link to this item: https://rima.ufrrj.br/jspui/handle/20.500.14407/14931
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCôrtes, Rafael Sonoda
dc.date.accessioned2023-12-22T03:08:30Z-
dc.date.available2023-12-22T03:08:30Z-
dc.date.issued2012-03-21
dc.identifier.citationCÕRTES, Rafael Sonoda. Infarto do miocárdio como modelo de depressão em ratos: estudo seriado. 2012. 82 f. Dissertação (Mestrado Multicêntrico em Ciências Fisiológicas) - Instituto de Ciências Biológicas e da Saúde, Universidade Federal Rural do Rio de Janeiro, Seropédica, 2012.por
dc.identifier.urihttps://rima.ufrrj.br/jspui/handle/20.500.14407/14931-
dc.description.abstractAs doenças cardiovasculares, especialmente o infarto do miocárdio (IM), representam um dos principais desafios para medicina no mundo inteiro. Estudos recentes mostram que os pacientes que apresentam algum tipo de doença cardiovascular possuem maiores chances de desenvolverem depressão. Por outro lado, indivíduos saudáveis do ponto de vista cardiovascular, mas que desenvolveram depressão são mais suscetíveis a eventos cardíacos. Assim, considerando a falta de estudos experimentais e a relação bidirecional entre o IM e a depressão, estudamos o possível efeito da insuficiência cardíaca (IC) induzida pelo IM experimental por meio da oclusão permanente da artéria coronária esquerda no comportamento padrão de ratos Wistar. Para tanto, foram utilizados o Teste do Campo Aberto (TCA), o Teste do Labirinto em Cruz Elevado (LCE) e o Teste da Preferência pela Sacarose (TPS), para identificar possíveis sinais análogos à depressão e também à ansiedade de humanos, 3, 14, 35 e 63 dias após o IM. Para avaliar a influência do desequilíbrio autonômico cardíaco induzido pelo IM nas alterações comportamentais, foi realizado o estudo da variabilidade da frequência cardíaca (VFC), nos mesmos dias. Finalmente, objetivando estudar a contribuição de possíveis alterações da transmissão serotonérgica nas alterações comportamentais e autonômicas, foi administrada fluoxetina (inibidor da recaptação de serotonina, 10 mg/kg) ou veículo, ambos por gavagem, em grupos infartados e sham, durante todo o protocolo. A expressão gênica de uma das enzimas precursoras da serotonina, triptofano hidroxilase tipo 2 (TPH2), também foi estudada por PCR em tempo real em todos os grupos. O grupo infartado mostrou sinais de depressão como diminuição da atividade exploratória e anedonia, que foram quase completamente inibidas pela fluoxetina. O grupo infartado mostrou alteração no tônus simpático cardíaco percebido pelo aumento das ondas de baixa freqüência na análise espectral, em relação ao sham. O tratamento com fluoxetina não alterou este parâmetro no grupo infartado. A expressão de TPH2 diminuiu no grupo infartado comparada ao sham e desta vez, o tratamento com fluoxetina normalizou este parâmetro. Baseado nos dados obtidos no presente estudo, concluímos que o IM experimental em ratos induz sinais de depressão, que são revertidos pelo tratamento com fluoxetina e que alterações no balanço autonômico cardíaco antecedem os distúrbios comportamentais, podendo assim, estar relacionado com o início dos sinais de depressão.por
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES, Brasil.por
dc.formatapplication/pdf*
dc.languageporpor
dc.publisherUniversidade Federal Rural do Rio de Janeiropor
dc.rightsAcesso Abertopor
dc.subjectInfarto do Miocárdiopor
dc.subjectdepressãopor
dc.subjectserotoninapor
dc.subjectMyocardial infarctioneng
dc.subjectdepressioneng
dc.subjectserotonineng
dc.titleInfarto do miocárdio como modelo de depressão em ratos: estudo seriadopor
dc.title.alternativeMyocardial infarction as a model of depression in rats: a time course studyeng
dc.typeDissertaçãopor
dc.description.abstractOtherCardiovascular diseases, especially myocardial infarction, represent a major challenge to medicine in the world. Recent studies show that patients who have some type of cardiovascular disease are more likely to develop depression. Furthermore, the healthy cardiovascular standpoint, but developed depression are more susceptible to cardiac events. Thus, considering the lack of experimental studies and the bidirectional relationship between depression and MI, we studied the possible effect of heart failure- induced experimental MI by permanent occlusion of the left coronary artery in the default behavior of Wistar rats. For this purpose, we used the Open Field Test, the Test of the Elevated Plus Maze and the Test of Preference for Sucrose, to identify possible signs similar to the psychological anxiety and depression in humans, 3, 14, 35 and 63 days after MI. To evaluate the influence of cardiac autonomic imbalance induced by IM in behavioral changes, we performed a study of heart rate variability. Finally, in order to study the contribution of possible changes in serotonergic transmission in the autonomic and behavioral changes, we gave fluoxetine (serotonin reuptake inhibitor, 10 mg / kg) or vehicle, both by gavage in sham and infarcted groups throughout the protocol. The gene expression of an enzyme precursor of serotonin, tryptophan hydroxylase type 2 (TPH2), was also studied in real time PCR in all groups. The infarcted group showed signs of depression such as reduced exploratory activity and anhedonia, which were almost completely inhibited by fluoxetine. The infarcted group showed changes in cardiac sympathetic tone seen by the increase of low frequency waves in the spectral analysis, compared to sham. Treatment with fluoxetine did not alter this parameter in the infarcted group. TPH2 expression decreased in the infarcted compared to sham and this time, fluoxetine treatment normalized this parameter. Based on data obtained in this study, we conclude that the IM in rats induces signs of depression that are reversed by treatment with fluoxetine and that alterations in cardiac autonomic balance preceding behavioral disturbances may be related to the signs of depression.eng
dc.contributor.advisor1Olivares, Emerson Lopes
dc.contributor.advisor1ID027.886.707-37por
dc.contributor.advisor1Latteshttp://lattes.cnpq.br/1361659701207857por
dc.contributor.referee1Nascimento, José Hamilton Matheus
dc.contributor.referee2Rocha, Fábio Fagundes da
dc.creator.ID116.692.957-45por
dc.creator.Latteshttp://lattes.cnpq.br/2640160789308974por
dc.publisher.countryBrasilpor
dc.publisher.departmentInstituto de Ciências Biológicas e da Saúdepor
dc.publisher.initialsUFRRJpor
dc.publisher.programPrograma Multicêntrico de Pós-Graduação em Ciências Fisiológicaspor
dc.relation.referencesAbrams JK, Johnson PL, Hollis JH, Lowry CA. Anatomic and functional topography of the dorsal raphe nucleus. Ann New York Acad Sci; 1018: 46 - 57, 2004. Akselrod S, Gordon D, Ubel FA, Shannon DC, Barger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat cardiovascular control. Science; 213: 220-2, 1981. Apóstolo JL, Figueiredo MH, Mendes AC, Rodrigues MA. Rev Lat Am Enfermagem; Mar-Apr; 19(2): 348-53, 2011. Archer, J. Tests for emotionality in rats and mice: a review. Anim Behav; May; 21(2) 205 - 235, 1973. Aubert AE, Ramaekers D, Beckers F, Breem R, Denef C, Van de Werf F, Ector H. The analysis of heart rate variability in unrestrained rats. Validation of method and results. Comput Methods Programs Biomed; 60: 197 – 213, 1999. Badoer E. Hypothalamic paraventricular nucleus and cardiovascular regulation. Clin Exp Pharmacol Physiol; 28: 95 – 99, 2001. Baker GB, Hiob LE, Dewhurst WG. Effects of monoamine oxidase inhibitors on release of dopamine and 5-hydroxytryptamine from rat striatum in vitro. Cell Mol Biol Incl Cyto Enzymol; 26(2):183-6, 1980. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Brenchley C, Socratous F, Kaye DM, Schlaich MP, Hickie I, Lambert GW. Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk? J Hypertens; 25: 2117–2124, 2007. Baumann P. Pharmacotherapy of depression: recent developments; Sep 19; 3(125): 2079-80, 2083-4, 2007. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measure of heart period variability and mortality after myocardial infarction. Circulation; 85: 164-71, 1992. Blier P. The pharmacology of putative early-onset antidepressant strategies. Eur Neuropsychopharmacol; 13: 57-66, 2003. Borelli KG, Nobre MJ, Brandão ML, Coimbra NC. Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of 71 dorsolateral and lateral columns of the periaqueductal gray matter. Pharmacol Biochem Behav; Mar; 77(3): 557-66, 2004. Bunney WE, Davis J M. Norepinephrine in depressive reactions.Arch. Gen. Psychiatry; 13: 483-494, 1965. Caraci F, Copani A, Nicoletti F, Drago F. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol; 626: 64-71, 2010. Carnevali L, Mastorci F, Graiani G, Razzoli M, Trombini M, Pico-Alfonso MA, Arban R, Grippo AJ, Quaini F, Sgoifo A. Social defeat and isolation induce clear signs of a depression-like state, but modest cardiac alterations in wild-type rats. Physiol Behav; Feb 7;106(2):142-150, 2012. [Epub ahead of print] Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res; 32:159–164, 1988b. Castillo AR, Recondo R, Asbahr FR, Manfro GG. Transtornos de ansiedade. Rev Bras Psiquiatr; 22(Supl II): 20-3, 2000. Courvoisier H, Moisan MP, Sarrieau A, Hendley ED, Mormède P. Behavioral and neuroendocrine reactivity to stress in the WKHA/WKY inbred rat strains: a multifactorial and genetic analysis. Brain Res; 743, n. 1-2: 77-85, 1996. Del Porto, José Alberto. Conceito e diagnóstico. Rev Bras Psiquiatr; 21 s.1 May, 1999. DSM-IV-TR- Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA. Heart rate as a prognostic factor for coronary heart disease and mortality: Findings in three Chicago epidemiologic studies. Am J Epidemiol; 112: 736–749, 1980. Du XJ, Cox HS, Dart AM, Esler MD. Depression of efferent parasympathetic control of heart rate in rats withmyocardial infarction: effect of losartan. J Cardiovasc Pharmacol. Jun;31(6):937-44, 1998. 72 Erhardt L, Herlitz J, Bossaert L. Task force on the management of chest pain. Eur Heart J; 23 (15): 1153–76, 2002. Esler M, Turbott J, Schwarz R, Leonard B, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry; 39: 295–300, 1982. Factor SM. Pathophysiology of myocardial ischemia. In: Hurst JW, Schlant, RC, Rackley CE, Sonnenblick EH, Wenger NK. Ed The Heart. Arteries and veins. 7 ed. New York, Mc Graw, Cap. 49: 940-59, 1990. Faria Tde O, Baldo MP, Simões MR, Pereira RB, Mill JG, Vassallo DV, Stefanon I. Body weight loss after myocardial infarction in rats as a marker of early heart failure development. ; May;42(4):274-80, 2011. Farris SG, Epstein EE, McCrady BS, Hunter-Reel D. Do Co-morbid Anxiety Disorders Predict Drinking Outcomes in Women with Alcohol Use Disorders? Alcohol Alcohol; Jan 2. [Epub ahead of print], 2012. Felder JN, Smoski MJ, Kozink RV, Froeliger B, McClernon FJ, Bizzell J, Petty C, Dichter GS. Neural mechanisms of subclinical depressive symptoms in women: a pilot functional brain imaging study. BMC Psychiatry. Sep 21;12(1):152, 2012. [Epub ahead of print] Ferrari R, Censi S, Mastrorilli F, Boraso A. Prognostic benefits of heart rate reduction in cardiovascular disease. Eur Heart J; 5(Suppl. G): G10–G14, 2003. Fisar Z, Hroudová J, Raboch J. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro Endocrinol Lett; 31(5): 645-56, 2010. Furlan R, Guzzetti S, Crivellaro W et al. Continuous 24-hour assessment of neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation; 81: 537-47, 1990. Forbes LM, Chaney RH. Cardiovascular changes during acute depression. Psychosomatics; 21: 472–477, 1980. Freedland KE, Rich MW, Skala JA, Carney RM, Davila-Roman VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom; Med 65: 119-128, 2003. Fregnil F, Pascual-Leone A. Estimulação magnética transcraniana: uma nova ferramenta para o tratamento da depressão? Rev. Psiq. Clín; 28 (5): 253-265, 2001. 73 Gascón MR, Capitão CG, Casseb J, Nogueira-Martins MC, Smid J, Oliveira AC. Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients. Braz J Infect Dis; Dec; 15(6): 578-82, 2011. Glassman AH. Depression and cardiovascular comorbidity. Dialogues Clin Neurosci; 9: 9–17, 2007. Goodman & Gilman. As bases farmacológicas da terapêutica. 9a. ed. Rio Janeiro, Guanabara Koogan, 1996. Gordon D, Guyton JR, Karnovsky N. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest; 45: 14–27, 1981. Gorman JM. Comorbid depression and anxiety spectrum disorders. Depress Anxiety; 4(4): 160-8, 1996-1997. Graeff F G & Brandão M L. Neurobiologia das doenças mentais, São Paulo: Lemos Editorial, 1993. Grippo AJ, Beltz TG, Weiss RM, Johnson AK. The effects of chronic fluoxetine treatment on chronic mild stress-induced cardiovascular changes and anhedonia. Biol Psychiatry. Feb 15; 59(4): 309-16, 2006. Epub 2005 Sep 9. Grippo AJ, Francis J, Weiss RM, Felder RB, Johnson AK. Cytokine mediation of experimental heart failure-induced anhedonia. Am J Physiol Regul Integr Comp Physiol; Mar;284(3):R666-73, 2003. Gutiérrez A, Saracíbar G, Casis L, Echevarría E, Rodríguez VM, Macarulla MT, Abecia LC, Portillo MP. Effects of fluoxetine administration on neuropeptide y and orexins in obese zucker rat hypothalamus. Obes Res; Jun;10(6):532-40, 2002. Hausberg M, Hillebrand U, Kisters K. Addressing sympathetic overactivity in major depressive disorder. J Hypertens; 25: 2004–2005, 2007. Hvelplund A, Galatius S, Madsen M, Sørensen R, Madsen JK, Iversen AZ, Tilsted HH, Helqvist S, Mortensen PE, Nielsen PH, Prescott E, Abildstrøm SZ. Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men.J Invasive Cardiol; Jan; 24(1): 19-24, 2012. Johns TNP, Olson BJ. Experimental myocardial infarction: I. Method of coronary occlusion in small animals. Ann Surg; 140: 675-682, 1954. Johnson AK, Grippo AJ. Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol; 57 Suppl 11: 5-29, 2006. 74 Kaplan HI, Sadock BJ & Grebb JA. Synopsis of Psychiatry; 7th ed. Baltimore: Williams e Wilkins, 1994. Kato T. Recent progress in mood disorder research. Brain Nerve; Feb; 64(2): 119-29, 2012. Kitney RI, Rompelman O. The Study of Heart Rate Variability. Oxford: Clarendon Press, 1980. Kleiger RE, Miller JP, Bigger JT, Moss AJ and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after myocardial infarction. Am J Cardiol; 59: 256-62, 1987. Krittayaphong R, Cascio WE, Light KC, Sheffield D, Golden RN, Finkel JB, Glekas G, Koch GG, Sheps DS. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores. Psychosom; Med 59: 231–235, 1997. Krogsgaard AR. Side-effects of reserpine in the treatment of essential hypertension: with special reference to weight gain and mental depression. Acta Med Scand; Dec 20;162(6):465-74, 1958. Koelch M, Pfalzer AK, Kliegl K, Rothenhöfer S, Ludolph AG, Fegert JM, Burger R, Mehler-Wex C, Stingl J, Taurines R, Egberts K, Gerlach M. Therapeutic Drug Monitoring of Children and Adolescents Treated with Fluoxetine. Pharmacopsychiatry; Nov 15. [Epub ahead of print], 2011. Kummar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc; 84: 917-938, 2009. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation; 115: 1067-1074, 2007. Livak KJ & Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-, 2001. Liu J, Garza JC, Bronner J, Kim CS, Zhang W, Lu XY. Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology (Berl); Jan;207(4):535-45, 2010. Epub 2009 Oct 13 75 Liu Q, Li B, Zhu HY, Wang YQ, Yu J, Wu GC. Glia atrophy in the hippocampus of chronic unpredictable stress-induced depression model rats is reversed by electroacupuncture treatment. J Affect Disord; Feb;128(3):309-13, 2011. Malkesman O, Braw Y, Zagoory-Sharon O, Golan O, Lavi-Avnon Y, Schroeder M, Overstreet DH, Yadid G, Weller A. Reward and anxiety in genetic animal models of childhood depression. Behav Brain Res; Oct 14; 164(1): 1-10, 2005. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull. Spring; 35(2): 5-49, 2001. Matto V, Allikmets L. Acute and chronic citalopram treatment differently modulates rat exploratory behavior in the exploration box test: no evidence for increased anxiety or changes in the [3H]raclopride binding. Pharmacology; v. 58, n. 2, 59-69, 1999. Mattos RM. Efficacy of tadalafil associated with once-weekly fluoxetine in premature ejaculation(Tese). Pesquisa em base de dados, documento 415021, 2005. McGill HC, Jr., McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr; 72: 1307S- 1315S, 2000. Meier CR, Schlienger RG, Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol; Aug;52(2):179-84, 2001. Meyer JH. Neuroimaging markers of cellular function in major depressive disorder: implications for therapeutics, personalized medicine, and prevention. Clin Pharmacol Ther; Feb; 91(2): 201-14, 2012. Mikics, E, Barsy, B, Barsvári B, Haller J. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm Behav; 48, n. 2: 152-62, 2005. Mohammad-Zadeh LF, MOSES L, GWALTNEY-BRANT, SM Serotonin: a review. J Vet Pharmacol Ther; 31, n. 3: 187-99, 2008 Moraes RSF, Ferlin EL. Variabilidad de la frecuencia cardíaca. Utilidad del análisis espectral para evaluar el sistema nervioso autónomo. Rev Arg Cardiol; 60: 77-80; 1992. Morales-Medina JC, Dumont Y, Benoit CE, Bastianetto S, Flores G, Fournier A, Quirion R. Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat 76 model of depression with co-morbid anxiety. Neuropharmacology; Jan;62(1): 200-8. Epub 2011 Jul 23, 2012. Mossner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC,Mu¨ ller N, Fallgatter AJ, Riederer P. Consensus paper of the WFSBP Task Force on Biological Markers: Biological markers in depression. World J Biol Psychiatry; 8: 141–174, 2007. Mostarda C, Rodrigues B, Vane M, Moreira ED, Rosa KT, Moraes-Silva IC, Lacchini S, Casarini DE, De Angelis K, Irigoyen MC. Autonomic impairment after myocardial infarction: role in cardiac remodelling and mortality. Clin Exp Pharmacol Physiol; Apr; 37(4): 447-52, 2010. Epub 2009 Oct 29. Murphy DL, Aulakh C, Mazzola-Pomietto P, Briggs NC. Neuroendocrine responses to serotonergic agonists as indices of the functional status of central serotonin neurotransmission in humans: A preliminary comparative analysis of neuroendocrine endpoints versus other endpoint measures. Behav Brain Res; 73: 209–214, 1996. Nemeroff CB, Owens MJ. Treatment of mood disorders. Nat Neurosci Suppl; 5: 1068-1070, 2002. NIMH- National Institute of Mental Health. Depression research at the National Institute of mental Health. 1999. Citado [2006 Março 30]. Disponível em: URL: http://www.nimh.nih.gov/publicat/depresfact.cfm. NIMH- National Institute of Mental Health. Health topics, 2011. Disponível em: URL: http://www.nimh.nih.gov/health/topics/depression/governmentinvolvement.index.shtm l. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure andits relationto left ventricula r function. Br Heart J. 1992 Jun;67(6):482-5. Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology; Jul-Aug;61(1-2):336-46, 2011. Epub 2011 Apr 23. Olivares EL, Costa ESRH, Werneck-de-Castro JP, Pinho-Ribeiro V, Silva MG, Ribeiro KC, Mattos EC, Goldenberg RC, Campos de Carvalho AC, Masuda MO Cellular cardiomyoplasty in large myocardial infarction: can the beneficial effect be enhanced by ACE-inhibitor therapy? Eur J Heart; 9: 558-567, 2007. 77 Olivares EL, Ribeiro VP, Werneck de Castro JP, Ribeiro KC, Mattos EC, Goldenberg RC, Mill JG, Dohmann HF, dos Santos RR, de Carvalho AC, Masuda MO. Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts. Am J Physiol Heart Circ Physiol; 287: H464-470, 2004. Ormel, J. Impact of mental disorderes on disability and quality of life in Europe: results from the European Study of Mental Disorders. Psychiatrica Scandinavica; Supplementum; 110 (suppl 421): p 36, 2004. Oswald I, Brezinova LE & Dunleavy DLF. On the slowness of action of tricyclic antidepressant drugs. Br. J. Psychiatry; 120, 673-677, 1972. Paxinos, G & Watson, C. The rat brain in stereotaxic coordinates. San Diego, CA, Academic Press, 1997. Pellow S, Chopin P, File SE, Briley M. Validation of open closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149- 167, 1985. Pereira-Junior PP, Chaves EA, Costa ESRH, Masuda MO, de Carvalho AC, Nascimento JH. Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur J Appl Physiol; 96: 487-494, 2006. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. ; Apr;44(4):503-12, 1979. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol; 260: H1406-1414, 1991. Pitzalis MV, Iacoviello M, Todarello O, Fioretti A, Guida P, Massari F, Mastropasqua F, Russo GD, Rizzon P. Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction. Am Heart J, 141:765–771, 2001.. Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation; 94:3123-3129, 1996. Prickaerts J, Raaijmakers W, Blokland A. Effects of myocardial infarction and captopril therapy on anxiety-related behaviors in the rat. Physiol Behav; 60:43-50, 1996. Porsolt RD. Animal models of depression: utility for transgenic research. Rev Neurosci;11(1):53-8, 2000. 78 PRUT L, BELZUNG C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviours: a review. Eur J Pharmacol; 463, n. 1-3: 3-33, 2003. RANG, H. P., DALE, J. M., RITTER, J. M., et al. Rang and Dale’s: Pharmacology. 6ed. Nova Iorque: Churchill/Livingstone, 2006 Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord; 32:271–275, 1994b. Renoir T, Zajac MS, Du X, Pang TY, Leang L, Chevarin C, Lanfumey L, Hannan AJ. Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression. PLoS One; 6(7): e22133, 2011. Epub 2011 Jul 8. Reis, Amália Faria dos. Disfunção parassimpática, variabilidade da freqüência cardíaca e estimulação colinérgica após infarto agudo do miocárdico. Arq. Bras. Cardiol:, vol.70, n.3, pp. 193-199, 1998. REIS LC. Role of the serotoninergic system in the sodium appetite. An Acad Bras Cienc; 79, n. 2: 261-83, 2007. RODGERS, R.J; COLE, J.C. Influence of social isolation, gender, strain, and prior novelty on plus-maze behavior in mice. Physiol Behav; 54, n. 4: 729-36, 1993. Rodgers RJ, Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev; 21, n. 6: 801-10, 1997. Rodgers RJ, Johnson NJT. Factor analysus of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav; 52, n. 2: 297-303, 1995. Ryan C, Hollenberg M, Harvey DB, Gwynn R. Impaired parasympathetic responses in patients after myocardial infarction. Am J Cardiol; 37:1013–1018, 1976. Rybnikova E, Mironova V, Pivina S, Tulkova E, Ordyan N, Vataeva L, Vershinina E, Abritalin E, Kolchev A, Nalivaeva N, Turner AJ, Samoilov M. Antidepressant-like effects of mild hypoxia preconditioning in the learned helplessness model in rats. Neurosci Lett; May 7;417(3):234-9, 2007. Epub 2007 Feb 22. Rygula R, Abumaria N, Flugge G, Fuchs E, Ruther E, Havemann-Reinecke U. Anhedonia and motivational deficits in rats: impact of chronic socialstress. Behav Brain Res; 162:127–34, 2005. Saidov AB, Israilov RI. Morphological characteristics of cardiomyocyte death in the experimental myocardial infarction in rats with various emotional reaction. Morfologiia; 122(4):50-2, 2002. 79 Sanders BJ, Lawler JE. The borderline hypertensive rat (BHR) as a model for environmentally-induced hypertension: a review and update. Neurosci Biobehav Rev; Summer;16(2):207-17, 1992. Saul JP. Beat-to-beat variations of heart rate reflect modulation of cardiac autonomic outflow. NIPS; 5: 32-7, 1990. Salleh MA, Papakostas I, Zervas I, Christodoulou G. Eletroconvulsoterapia: critérios e recomendações da Associação Mundial de Psiquiatria. Rev. Psiq. Clín; 33 (5): 262- 267, 2006 Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry; 122: 509-522, 1965.. Schins A, Van Kroonenburgh M, Van Laere K, D'Haenen H, Lousberg R, Crijns H, Eersels J, Honig A. Increased cerebral serotonin-2A receptor binding in depressed patients with myocardial infarction. Psychiatry Res; 139:155-163, 2005. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, Zucker HD. The nature and course of depression following myocardial infarction. Arch Intern Med; 149:1785-1789, 1989. Schloss P, Henn FA. New insights into the mechanisms of antidepressant therapy. Pharmacology & Therapeutics; 102:47-60, 2004. Schoemaker RG, Smits JF. Behavioral changes following chronic myocardial infarction in rats. Physiol Behav; Sep;56(3):585-9, 1994. Schoemaker RG, Kalkman EA, Smits JF. 'Quality of life' after therapy in rats with myocardial infarction: dissociation between hemodynamic and behavioral improvement. Eur J Pharmacol; Feb 29;298(1):17-25, 1996. Seligman MEP. Helplessness. On development, depression and death, 1992. New York, W.H. Freeman and Company (Trabalho original publicado em 1975) Shishkina GT, Kalinina TS, Dygalo NN. Up-regulation of tryptophan hydroxylase-2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect. Neuroscience; 150:404-412, 2007. Sierksma AS, van den Hove DL, Steinbusch HW, Prickaerts J. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? Eur J Pharmacol; 626:72-82, 2010. Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H, Kangawa K. Ghrelin suppresses cardiac sympathetic activity and prevents early left 80 ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol; Jan;294(1):H426-32, 2008. Epub 2007 Nov 16. Sole MJ, Hussain MN, Lixfeld W. Activation of brain catecholaminergic neurons by cardiac vagal afferents during acute myocardial ischemia in the rat. Circ Res; 47:166- 172, 1980. Sole MJ, Versteeg DH, de Kloet ER, Hussain N, Lixfeld W. The identification of specific serotonergic nuclei inhibited by cardiac vagal afferents during acute myocardial ischemia in the rat. Brain Res 265:55–61, 1983. Spadaro J, Fishbein MC, Hare C, Pfeffer MA, Maroko PR. Characterization of myocardial infarcts in the rat. Arch Pathol Lab Med; 104:179-183, 1980. Spiegel D. Cancer and depression. Br J Psychiatry; Suppl:109-116, 1996. Spijkerman T, de Jonge P, van den Brink RH, Jansen JH, May JF, Crijns HJ, Ormel J. Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes. Gen Hosp Psychiatry; 27:411-417, 2005. Stahl SM. Psicofarmacologia: bases neurocientíficas e aplicações clínicas. Rio de Janeiro: MEDSI – Editora Médica e Científica Ltda, 1998. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, Ounpuu S, Yusuf S. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation; 112:3554-3561, 2005. Stoop CH, Spek VR, Pop VJ, Pouwer F. Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care. BMC Fam Pract; Dec 15; 12: 139, 2011. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation; 93: 1043-65, 1996. Trindade DC, Trindade RC, Marassi MP, Martins OP, Costa-e-Sousa RH, Mattos EC, Marinho-Jr A, Reis LC, Olivares EL. Role of renin-angiotensin system in development of heart failure induced by myocardial infarction in rats. An Acad Bras Cienc; 79:251- 259, 2007. Uebelacker LA, Keitner GB, Ryan CE, Miller IW. Characterizing the long-term course of individuals with major depressive disorder. The Journal of Nervous and Mental Disease; 192: 65-68, 2004. 81 Van der Heiden C, Muris P, van der Molen HT. Randomized controlled trial on the effectiveness of metacognitive therapy and intolerance-of-uncertainty therapy for generalized anxiety disorder. Behav Res Ther; Feb; 50(2): 100-9, 2012. Epub 2011 Dec 21. Van der Staay FJ, Kerbusch S, Raaijmakers W. Genetic correlations in validating emotionality. Behav Genet; 20:51-62, 1990. Van Praag HM & Korf J. Endogenous depression with andwithout disturbances of 5- hydroxytryptamine metabolism: a biochemicalclassification? Psychopharmacol; 19: 148-152. 1971. van Zwieten PA, Blauw GJ, van Brummelen P. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs. Clin Physiol Biochem; 8(Supp. 3): 1–18, 1990.. Watkins LL, Grossman P. Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease. Am Heart J; 137:453–457, 1999. White HD, Chew DP. Acute myocardial infarction. Lancet; 372:570-584, 2008. WHO - World Health Organization: Fifty-fourth World Health Assembly- Ministerial round tables- Mental health 2001. Citado [2006 Março30]. Disponível em: URL: www.who.int/gb/ebwha/pdf_files/WHA54/ea54d4.pdf. WHO - World Health Organization : CVD prevention and control : missed opportunities. Cardiovascular diseases, 2011. Disponível em URL: www.who.int/cardiovascular_diseases/en/. WHO-World Health Organization: The global burden of disease, 2008. Disponível em URL: http://www.who.int/disabilities/world_report/2011/report.pdf. Willner, P. Animal models of depression: on overview. Pharmacology and Therapeutics; 45: 425-455, 1990. Wu J, Guo Z, Wang LL, Zhang RL. Degeneration of sensory afferent nerves enhances pulmonary inflammatory alterations in acute myocardial infarction in rats. Cardiovasc Pathol; Jun 9, 2011. [Epub ahead of print]. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart; 95 (3): 198-202. Epub 2008 Aug 15.. 82 Zhang RL, Guo Z, Wang LL, Wu J. Degeneration of capsaicin sensitive sensory nerves enhances myocardial injury in acute myocardial infarction in rats. Int J Cardiol; Apr 5, 2011. [Epub ahead of print]. Zhang Y, Raap DK, Garcia F, Serres F, Ma Q, Battaglia G, et al. Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats. Brain Res; 855:58–66, 2000.por
dc.subject.cnpqFisiologiapor
dc.thumbnail.urlhttps://tede.ufrrj.br/retrieve/61285/2012%20-%20Rafael%20Sonoda%20C%c3%b4rtes.pdf.jpg*
dc.originais.urihttps://tede.ufrrj.br/jspui/handle/jspui/3742
dc.originais.provenanceSubmitted by Sandra Pereira (srpereira@ufrrj.br) on 2020-07-23T14:05:04Z No. of bitstreams: 1 2012 - Rafael Sonoda Côrtes.pdf: 1408833 bytes, checksum: 6b042261b915dfed2d0edc68fdd77495 (MD5)eng
dc.originais.provenanceMade available in DSpace on 2020-07-23T14:05:04Z (GMT). No. of bitstreams: 1 2012 - Rafael Sonoda Côrtes.pdf: 1408833 bytes, checksum: 6b042261b915dfed2d0edc68fdd77495 (MD5) Previous issue date: 2012-03-21eng
Appears in Collections:Mestrado Multicêntrico em Ciências Fisiológicas

Se for cadastrado no RIMA, poderá receber informações por email.
Se ainda não tem uma conta, cadastre-se aqui!

Files in This Item:
File Description SizeFormat 
2012 - Rafael Sonoda Côrtes.pdf2012 - Rafael Sonoda Côrtes1.38 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.